RT @jgong15
@PamelaKunzMD novel agents targeting #SSTR, #MGMT deficiency & temodar response, trials to watch in #GEPNETs & #NEC and #PRRT in #GEPNETS @TumorBoardTues and new concept of #PRRT rechallenge #SBNET

@CSCancerCenter 4th Annual GI Tumor conf http://cedars.cloud-cme.com/gicancercme @OncoAlert